Exact Sciences posts wider loss, but sales rise 50%

Kathleen Gallagher of the Journal Sentinel reports: "Madison diagnostic test maker Exact Sciences Corp. reported a wider loss in the fourth quarter on higher revenue. Exact is rolling out its first product after receiving approvals in August from the U.S. Food and Drug Administration and the Centers for Medicare and Medicaid Services." (JOURNAL SENTINEL 2,24)
To access this content, you must purchase a Premium membership, or log in if you are a member.

STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.

Subscribe here for a FREE 14 day trial of our daily news roundup.

You have Successfully Subscribed!

Pin It on Pinterest